{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:41:22Z","timestamp":1769272882766,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1-2","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Prevalence studies on ocular diseases among veterans are limited and underreported. In this retrospective study, we examined the prevalence of vision-threatening ocular diseases among North Carolina veterans. We assessed the prevalence of 6 serious ocular conditions among veterans receiving primary care at the Salisbury Veterans Affairs Health Care System (SVAHCS) in North Carolina to better understand ocular disease prevalence among veterans. Glaucoma, the most common ocular disease in this population, underscores the need for targeted interventions to mitigate vision loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>A retrospective review of medical records from 34,530 veterans enrolled in SVAHCS primary care was conducted. Data collected included demographics such as age, gender, and race. The study focused on 6 vision-threatening diseases: glaucoma, vision-threatening diabetic retinopathy (VTDR), exudative age-related macular degeneration (AMD), retinal vein occlusions (RVO), retinal artery occlusions (RAO), and non-arteritic anterior ischemic optic neuropathy (NAION). Structured Query Language extracted disease frequency, and statistical analysis revealed prevalence rates and socio-demographic patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The average age of veterans was 69.5 years, with 94% male and 66% White. The most prevalent ocular condition was glaucoma (9%), followed by VTDR (1.3%), exudative AMD (0.9%), RVO (0.8%), RAO (0.4%), and NAION (0.4%). Older male veterans had a disproportionate burden of most ocular conditions. Racial disparities in disease prevalence highlight areas for focused healthcare strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals the significant burden of vision-threatening ocular diseases among North Carolina veterans, with glaucoma being the most prevalent. The findings emphasize the need for targeted screening and personalized interventions to prevent vision loss and address disparities. Further research should explore systemic and behavioral contributors to these trends, guiding evidence-based strategies to improve veterans\u2019 ocular health outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/milmed\/usaf381","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:03:15Z","timestamp":1752501795000},"page":"e380-e387","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Vision-Threatening Ocular Disease Among North Carolina Veterans"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4834-1228","authenticated-orcid":false,"given":"Charles N","family":"Davis","sequence":"first","affiliation":[{"name":"Salisbury Veteran Affairs Health Care System , 1601 Brenner Avenue , Salisbury, North Carolina 28144","place":[", United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Carnes","sequence":"additional","affiliation":[{"name":"University of North Carolina-Charlotte , Charlotte, NC, 9201 University City Blvd. , Charlotte, North Carolina 28223","place":[", United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Richardson","sequence":"additional","affiliation":[{"name":"Salisbury Veteran Affairs Health Care System , 1601 Brenner Avenue , Salisbury, North Carolina 28144","place":[", United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Brandon","sequence":"additional","affiliation":[{"name":"University of North Carolina-Charlotte , Charlotte, NC, 9201 University City Blvd. , Charlotte, North Carolina 28223","place":[", United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"2026012303272244600_usaf381-B1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0033-3182(99)71229-6","article-title":"Blindness, fear of sight loss, and suicide","volume":"40","author":"De Leo","year":"1999","journal-title":"Psychosomatics"},{"key":"2026012303272244600_usaf381-B2","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1007\/s11606-020-06110-8","article-title":"Automated extraction of structured data from text notes in the electronic medical record","volume":"36","author":"Flint","year":"2021","journal-title":"J Gen Intern Med"},{"key":"2026012303272244600_usaf381-B3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2021.09.010","article-title":"The Economic Burden of vision loss and blindness in the United States","volume":"129","author":"Rein","year":"2022","journal-title":"Ophthalmology"},{"key":"2026012303272244600_usaf381-B4","volume-title":"How the United States Racializes Latinos: White Hegemony and Its Consequences","author":"Cobas","year":"2009"},{"key":"2026012303272244600_usaf381-B5","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jamaophthalmol.2016.1158","article-title":"Burden of visual impairment and chronic diseases","volume":"134","author":"Park","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026012303272244600_usaf381-B6","first-page":"253","article-title":"Glaucoma: diagnosis and management","volume":"107","author":"Michels","year":"2023","journal-title":"Am Fam Physician"},{"key":"2026012303272244600_usaf381-B7","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026012303272244600_usaf381-B8","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1167\/iovs.15-18469","article-title":"Prevalence of glaucoma in the United States: the 2005-2008 National Health and Nutrition Examination Survey","volume":"57","author":"Gupta","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026012303272244600_usaf381-B9","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"2026012303272244600_usaf381-B10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ophtha.2023.07.020","article-title":"Trends in the diagnosed prevalence and incidence of major eye diseases in Medicare Part B fee-for-service beneficiaries 68 years of age or older","volume":"130","author":"Ehrlich","year":"2023","journal-title":"Ophthalmology"},{"key":"2026012303272244600_usaf381-B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.genhosppsych.2016.08.003","article-title":"Prevalence of diagnosed ocular disease in veterans with serious mental illness","volume":"43","author":"Saeedi","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"2026012303272244600_usaf381-B12","doi-asserted-by":"publisher","first-page":"b50","DOI":"10.2337\/diacare.27.suppl_2.B50","article-title":"Eye disease in veterans with diabetes","volume":"27 Suppl 2","author":"Orcutt","year":"2004","journal-title":"Diabetes Care"},{"key":"2026012303272244600_usaf381-B13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2016.09.030","article-title":"Trends in prevalence of diagnosed ocular disease and utilization of eye care services in American Veterans","volume":"173","author":"Saeedi","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2026012303272244600_usaf381-B14","doi-asserted-by":"publisher","first-page":"e218348","DOI":"10.1001\/jamanetworkopen.2021.8348","article-title":"Racial and ethnic disparities in primary open-angle glaucoma clinical trials: a systematic review and meta-analysis","volume":"4","author":"Allison","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026012303272244600_usaf381-B15","author":"Davis","year":"2023"},{"key":"2026012303272244600_usaf381-B16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13098-024-01532-4","article-title":"Association between metabolic syndrome and the risk of glaucoma: a meta-analysis of observational studies","volume":"16","author":"Li","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"2026012303272244600_usaf381-B17","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41598-025-85505-1","article-title":"Nationwide cohort study of primary open angle glaucoma risk and cardiovascular factors among in Korean glaucoma suspects","volume":"15","author":"Jung","year":"2025","journal-title":"Sci Rep"},{"key":"2026012303272244600_usaf381-B18","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1111\/aos.13758","article-title":"Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study","volume":"96","author":"Founti","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"2026012303272244600_usaf381-B19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2026012303272244600_usaf381-B20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"2026012303272244600_usaf381-B21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jamaophthalmol.2017.2553","article-title":"Vision-related functional burden of diabetic retinopathy across severity levels in the United States","volume":"135","author":"Willis","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2026012303272244600_usaf381-B22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ophtha.2010.07.023","article-title":"Prevalence and predictors of ocular complications associated with cataract surgery in United States Veterans","volume":"118","author":"Greenberg","year":"2011","journal-title":"Ophthalmology"},{"key":"2026012303272244600_usaf381-B23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ajo.2004.10.064","article-title":"A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center\u2014the Joslin Vision Network Eye Health Care Model","volume":"139","author":"Cavallerano","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2026012303272244600_usaf381-B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1756-0500-3-153","article-title":"Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2","volume":"3","author":"Chatziralli","year":"2010","journal-title":"BMC Res Notes"},{"key":"2026012303272244600_usaf381-B25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.7326\/0003-4819-141-4-200408170-00007","article-title":"Diabetes care quality in the veterans affairs health care system and commercial managed care: the TRIAD study","volume":"141","author":"Kerr","year":"2004","journal-title":"Ann Intern Med"},{"key":"2026012303272244600_usaf381-B26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ajo.2005.08.063","article-title":"Diabetic retinopathy in a multi-ethnic cohort in the United States","volume":"141","author":"Wong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"2026012303272244600_usaf381-B27","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","article-title":"Global burden of dry age-related macular degeneration: a targeted literature review","volume":"43","author":"Schultz","year":"2021","journal-title":"Clin Ther"},{"key":"2026012303272244600_usaf381-B28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"2026012303272244600_usaf381-B29","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","article-title":"Age-related macular degeneration and blindness due to neovascular maculopathy","volume":"102","author":"Ferris","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"2026012303272244600_usaf381-B30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","article-title":"Prevalence of age-related macular degeneration in the US in 2019","volume":"140","author":"Rein","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"2026012303272244600_usaf381-B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","article-title":"Prevalence of age-related macular degeneration in the US population","volume":"129","author":"Klein","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"2026012303272244600_usaf381-B32","doi-asserted-by":"publisher","first-page":"e071921","DOI":"10.1136\/bmjopen-2023-071921","article-title":"Adverse COVID-19 outcomes in American Veterans with age-related macular degeneration: a case\u2013control study","volume":"13","author":"Armbrust","year":"2023","journal-title":"BMJ Open"},{"key":"2026012303272244600_usaf381-B33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","article-title":"Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis","volume":"113","author":"Klein","year":"2006","journal-title":"Ophthalmology"},{"key":"2026012303272244600_usaf381-B34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/STROKEAHA.115.010828","article-title":"Retinal artery occlusion and the risk of stroke development: twelve-year nationwide cohort study","volume":"47","author":"Rim","year":"2016","journal-title":"Stroke"},{"key":"2026012303272244600_usaf381-B35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ajo.2011.05.005","article-title":"The incidence of central retinal artery occlusion in Olmsted County, Minnesota","volume":"152","author":"Leavitt","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"2026012303272244600_usaf381-B36","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/STROKEAHA.119.027034","article-title":"Characteristics and outcomes of retinal artery occlusion: nationally representative data","volume":"51","author":"Schorr","year":"2020","journal-title":"Stroke"},{"key":"2026012303272244600_usaf381-B37","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1111\/aos.14500","article-title":"Neovascular glaucoma in patients with central retinal vein occlusion: a real-life study in the anti-VEGF era","volume":"99","author":"Casselholm De Salles","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"2026012303272244600_usaf381-B38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000494224","article-title":"Prevalence of retinal vein occlusion in Europe: a systematic review and meta-analysis","volume":"241","author":"Li","year":"2019","journal-title":"Ophthalmologica"},{"key":"2026012303272244600_usaf381-B39","first-page":"133","article-title":"The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study","volume":"98","author":"Klein","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2026012303272244600_usaf381-B40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"2026012303272244600_usaf381-B41","doi-asserted-by":"publisher","first-page":"724780","DOI":"10.1155\/2014\/724780","article-title":"Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data","volume":"2014","author":"Kolar","year":"2014","journal-title":"J Ophthalmol"},{"key":"2026012303272244600_usaf381-B42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/vision7040072","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview","volume":"7","author":"Salvetat","year":"2023","journal-title":"Vision"},{"key":"2026012303272244600_usaf381-B43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0002-9394(14)70999-7","article-title":"Incidence of nonarteritic anteripr ischemic optic neuropathy","volume":"123","author":"Hattenhauer","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"2026012303272244600_usaf381-B44","doi-asserted-by":"publisher","first-page":"618353","DOI":"10.3389\/fmed.2021.618353","article-title":"Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"key":"2026012303272244600_usaf381-B45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ajo.2006.10.006","article-title":"Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors","volume":"143","author":"Margo","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/191\/1-2\/e380\/63895502\/usaf381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/191\/1-2\/e380\/63895502\/usaf381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:27:29Z","timestamp":1769156849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/191\/1-2\/e380\/8219445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":45,"journal-issue":{"issue":"1-2","published-online":{"date-parts":[[2025,7,26]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaf381","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,7,26]]}}}